Refametinib (Standard)
Refametinib (Standard) is the analytical standard of Refametinib. This product is intended for research and analytical applications. Refametinib (BAY 869766; RDEA119) is an orally available, potent, non-ATP-competitive, selective, allosteric MEK1/MEK2 inhibitor with IC50s of 19 nM and 47 nM, respectively.
Product Specifications
CAS Number
923032-37-5
UNSPSC
12352100
Target
MEK; Reference Standards
Related Pathways
MAPK/ERK Pathway; Others
Field of Research
Cancer
Smiles
O=S(C1(C[C@H](O)CO)CC1)(NC(C(NC(C(F)=C2)=CC=C2I)=C3F)=C(OC)C=C3F)=O
Molecular Formula
C19H20F3IN2O5S
Molecular Weight
572.34
References & Citations
[1]Iverson C, et al. RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancer. Cancer Res. 2009 Sep 1;69 (17) :6839-47.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1134858 Inquire
Recombinant Acaryochloris marina Bifunctional pantoate ligase/cytidylate kinase (panC/cmk), partial
Sign In for Pricing
View Details 
X2088P 100 µg
Rabbit anti Human SET, Phosphatase 2A Inhibitor I2PP2A
Sign In for Pricing
View Details GTR15400987 1 Vial
Lentiviral human SH3PXD2A sgRNA gene knockout kit - Lentiviral human SH3PXD2A sgRNA gene knockout kit (100)
Sign In for Pricing
View Details 